6-K ·Filed May 14, 2026
Notable filing: 6-K
Actionable Insight • Neutral
Monitor for future CDMO contract announcements or revenue guidance updates. This hire alone does not warrant a trading action.
Final — all horizons settled through T+60d ⚠ clustered
BHST ▼ -49.52% at T+60d
NEUTRAL call -49.52% · α vs SPY -53.11% · entry $4.16 → $2.10
T+1d
-1.44%
call -1.44% · α -0.22%
$4.10
settled 6mo ago
T+5d
-8.17%
call -8.17% · α -7.46%
$3.82
settled 5mo ago
T+20d
-23.08%
call -23.08% · α -22.22%
$3.20
settled 5mo ago
T+60d
-49.52%
call -49.52% · α -53.11%
$2.10
settled 3mo ago
Price Chart
Loading chart...
Executive Summary
BioHarvest Sciences appointed Nedira Salzman-Frenkel as VP of Business Development for its CDMO division. The appointment is a routine organizational change with no material financial data disclosed — no revenue, earnings, contract values, or guidance were provided.
Key Facts
- Nedira Salzman-Frenkel appointed VP of Business Development for BioHarvest's CDMO division on May 12, 2026.
- Ms. Salzman-Frenkel previously secured approximately $30 million in CRO contracts at the Salzman Group.
- No financial terms, revenue targets, or contract values were disclosed in the filing.
- The filing is a routine business development hire with no material financial impact.
Financial Impact
No financial figures disclosed — appointment is a routine organizational change.
Risk Factors
- No assurance that new business development will lead to signed contracts or increased revenue.
- Forward-looking statements caution that increased revenue may not translate to net income or profitability.
Market Snapshot
Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
88% bullish (8 analysts)
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000026 |
| Document: bhsc_ex991.htm | 0001723464-26-000026 |
| Document: 0001723464-26-000026-index-headers.html | 0001723464-26-000026 |
| Document: 0001723464-26-000026-index.html | 0001723464-26-000026 |
| Document: 0001723464-26-000026.txt | 0001723464-26-000026 |
14 reports for BHST
67% Hit rate @ T+5 Went positive at some point 2 of 3 best @ T+60▲ +49.52%
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.68 (−3.73%) |
Oct 8, 2026 18d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.68 (+12.37%) |
Sep 15, 2026 5w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.68 (+1.20%) |
Sep 14, 2026 6w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.68 (−5.36%) |
Jul 15, 2026 14w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.68 (−41.06%) |
Jun 18, 2026 18w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.68 (−48.47%) |
May 28, 2026 21w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.68 (−56.93%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.68 (+59.62%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.62%) |
Showing 10 of 14
US Market Status
Market Open — Closes in 6h 3m
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers